Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Tricuspid atresia primary prevention
Introduction
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Overview
Effective measures for the primary prevention of tricuspid atresia as prenatal screening include fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness, fetal echocardiography between 18-22 weeks of pregnancy
Primary prevention
Primary prevention
- Effective measures for the primary prevention of tricuspid atresia as prenatal screening include:[1]
- Fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness.
- Fetal echocardiography between 18-22 weeks of pregnancy
References
References
- ↑ Galindo, A.; Comas, C.; MartÃnez, J. M.; Gutiérrez-Larraya, F.; Carrera, J. M.; Puerto, B.; Borrell, A.; Mortera, C.; de la Fuente, P. (2009). “Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation”. The Journal of Maternal-Fetal & Neonatal Medicine. 13 (3): 163–170. doi:10.1080/jmf.13.3.163.170. ISSN 1476-7058.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Kristin Feeney, B.S. [5]